Drugs / Shugan Jieyu capsules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05764798 | Nov 2022 → Dec 2024 | insomnia | Nanfang Hospital, Southern Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shugan Jieyu capsules | “Efficacy and safety of Shugan Jieyu capsules in combination with zolpidem for insomnia disorder with depressive symptoms: a double-blind randomized controlled trial.” PMID 41107798 ↗ Oct 2025 |
| Known as | Shugan Jieyu capsule | “Efficacy and safety of Shugan Jieyu capsules in combination with zolpidem for insomnia disorder with depressive symptoms: a double-blind randomized controlled trial.” PMID 41107798 ↗ Oct 2025 |
| Route | Oral | “Shugan Jieyu capsule and zolpidem orally for 8 consecutive weeks” NCT05764798 ↗ |